Medical device
Medical device firm Caisson Interventional LLC plans to expand its Maple Grove facilities by 30,000 square foot and add 50 jobs.
The plan is an effort to ward off pressure to break up the firm by activist investor Elliott Advisors.
The FDA laid out eight observations it determined needed correction at the facility.
Rani said the latest funding round brings its coffers a total of $142M.
The opportunities for this DNA test maker are tremendous. But there are challenges, also.
The June 30, 2017 lawsuit asserts that the EndoWrist violates seven Ethicon patents.
The company expected a submission date in late 2018.
Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.
A look at Precision Therapeutics’ upcoming catalysts.
A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.
PRESS RELEASES